Global Angina Pectoris Drugs Market Research Report 2023

Report ID: 1983296 | Published Date: Jan 2025 | No. of Page: 88 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Angina Pectoris Drugs Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Beta Blockers
        1.2.3 Calcium Antagonists
        1.2.4 Anticoagulants
        1.2.5 Anti-Platelets
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Angina Pectoris Drugs Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 ASCs
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Angina Pectoris Drugs Market Perspective (2017-2028)
    2.2 Angina Pectoris Drugs Growth Trends by Region
        2.2.1 Angina Pectoris Drugs Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Angina Pectoris Drugs Historic Market Size by Region (2017-2022)
        2.2.3 Angina Pectoris Drugs Forecasted Market Size by Region (2023-2028)
    2.3 Angina Pectoris Drugs Market Dynamics
        2.3.1 Angina Pectoris Drugs Industry Trends
        2.3.2 Angina Pectoris Drugs Market Drivers
        2.3.3 Angina Pectoris Drugs Market Challenges
        2.3.4 Angina Pectoris Drugs Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Angina Pectoris Drugs Players by Revenue
        3.1.1 Global Top Angina Pectoris Drugs Players by Revenue (2017-2022)
        3.1.2 Global Angina Pectoris Drugs Revenue Market Share by Players (2017-2022)
    3.2 Global Angina Pectoris Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Angina Pectoris Drugs Revenue
    3.4 Global Angina Pectoris Drugs Market Concentration Ratio
        3.4.1 Global Angina Pectoris Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Angina Pectoris Drugs Revenue in 2021
    3.5 Angina Pectoris Drugs Key Players Head office and Area Served
    3.6 Key Players Angina Pectoris Drugs Product Solution and Service
    3.7 Date of Enter into Angina Pectoris Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Angina Pectoris Drugs Breakdown Data by Type
    4.1 Global Angina Pectoris Drugs Historic Market Size by Type (2017-2022)
    4.2 Global Angina Pectoris Drugs Forecasted Market Size by Type (2023-2028)
5 Angina Pectoris Drugs Breakdown Data by Application
    5.1 Global Angina Pectoris Drugs Historic Market Size by Application (2017-2022)
    5.2 Global Angina Pectoris Drugs Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Angina Pectoris Drugs Market Size (2017-2028)
    6.2 North America Angina Pectoris Drugs Market Size by Country (2017-2022)
    6.3 North America Angina Pectoris Drugs Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Angina Pectoris Drugs Market Size (2017-2028)
    7.2 Europe Angina Pectoris Drugs Market Size by Country (2017-2022)
    7.3 Europe Angina Pectoris Drugs Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Angina Pectoris Drugs Market Size (2017-2028)
    8.2 Asia-Pacific Angina Pectoris Drugs Market Size by Country (2017-2022)
    8.3 Asia-Pacific Angina Pectoris Drugs Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Angina Pectoris Drugs Market Size (2017-2028)
    9.2 Latin America Angina Pectoris Drugs Market Size by Country (2017-2022)
    9.3 Latin America Angina Pectoris Drugs Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Angina Pectoris Drugs Market Size (2017-2028)
    10.2 Middle East & Africa Angina Pectoris Drugs Market Size by Country (2017-2022)
    10.3 Middle East & Africa Angina Pectoris Drugs Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Detail
        11.1.2 Pfizer Business Overview
        11.1.3 Pfizer Angina Pectoris Drugs Introduction
        11.1.4 Pfizer Revenue in Angina Pectoris Drugs Business (2017-2022)
        11.1.5 Pfizer Recent Development
    11.2 Bayer
        11.2.1 Bayer Company Detail
        11.2.2 Bayer Business Overview
        11.2.3 Bayer Angina Pectoris Drugs Introduction
        11.2.4 Bayer Revenue in Angina Pectoris Drugs Business (2017-2022)
        11.2.5 Bayer Recent Development
    11.3 AstraZeneca
        11.3.1 AstraZeneca Company Detail
        11.3.2 AstraZeneca Business Overview
        11.3.3 AstraZeneca Angina Pectoris Drugs Introduction
        11.3.4 AstraZeneca Revenue in Angina Pectoris Drugs Business (2017-2022)
        11.3.5 AstraZeneca Recent Development
    11.4 Gilead
        11.4.1 Gilead Company Detail
        11.4.2 Gilead Business Overview
        11.4.3 Gilead Angina Pectoris Drugs Introduction
        11.4.4 Gilead Revenue in Angina Pectoris Drugs Business (2017-2022)
        11.4.5 Gilead Recent Development
    11.5 Novartis
        11.5.1 Novartis Company Detail
        11.5.2 Novartis Business Overview
        11.5.3 Novartis Angina Pectoris Drugs Introduction
        11.5.4 Novartis Revenue in Angina Pectoris Drugs Business (2017-2022)
        11.5.5 Novartis Recent Development
    11.6 GlaxoSmithKline
        11.6.1 GlaxoSmithKline Company Detail
        11.6.2 GlaxoSmithKline Business Overview
        11.6.3 GlaxoSmithKline Angina Pectoris Drugs Introduction
        11.6.4 GlaxoSmithKline Revenue in Angina Pectoris Drugs Business (2017-2022)
        11.6.5 GlaxoSmithKline Recent Development
    11.7 Merck
        11.7.1 Merck Company Detail
        11.7.2 Merck Business Overview
        11.7.3 Merck Angina Pectoris Drugs Introduction
        11.7.4 Merck Revenue in Angina Pectoris Drugs Business (2017-2022)
        11.7.5 Merck Recent Development
    11.8 Mylan
        11.8.1 Mylan Company Detail
        11.8.2 Mylan Business Overview
        11.8.3 Mylan Angina Pectoris Drugs Introduction
        11.8.4 Mylan Revenue in Angina Pectoris Drugs Business (2017-2022)
        11.8.5 Mylan Recent Development
    11.9 Teva Pharmaceutical
        11.9.1 Teva Pharmaceutical Company Detail
        11.9.2 Teva Pharmaceutical Business Overview
        11.9.3 Teva Pharmaceutical Angina Pectoris Drugs Introduction
        11.9.4 Teva Pharmaceutical Revenue in Angina Pectoris Drugs Business (2017-2022)
        11.9.5 Teva Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Angina Pectoris Drugs Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Beta Blockers
    Table 3. Key Players of Calcium Antagonists
    Table 4. Key Players of Anticoagulants
    Table 5. Key Players of Anti-Platelets
    Table 6. Key Players of Others
    Table 7. Global Angina Pectoris Drugs Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Angina Pectoris Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Angina Pectoris Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Angina Pectoris Drugs Market Share by Region (2017-2022)
    Table 11. Global Angina Pectoris Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Angina Pectoris Drugs Market Share by Region (2023-2028)
    Table 13. Angina Pectoris Drugs Market Trends
    Table 14. Angina Pectoris Drugs Market Drivers
    Table 15. Angina Pectoris Drugs Market Challenges
    Table 16. Angina Pectoris Drugs Market Restraints
    Table 17. Global Angina Pectoris Drugs Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Angina Pectoris Drugs Market Share by Players (2017-2022)
    Table 19. Global Top Angina Pectoris Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Angina Pectoris Drugs as of 2021)
    Table 20. Ranking of Global Top Angina Pectoris Drugs Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Angina Pectoris Drugs Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Angina Pectoris Drugs Product Solution and Service
    Table 24. Date of Enter into Angina Pectoris Drugs Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Angina Pectoris Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Angina Pectoris Drugs Revenue Market Share by Type (2017-2022)
    Table 28. Global Angina Pectoris Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Angina Pectoris Drugs Revenue Market Share by Type (2023-2028)
    Table 30. Global Angina Pectoris Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Angina Pectoris Drugs Revenue Market Share by Application (2017-2022)
    Table 32. Global Angina Pectoris Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Angina Pectoris Drugs Revenue Market Share by Application (2023-2028)
    Table 34. North America Angina Pectoris Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 35. North America Angina Pectoris Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Europe Angina Pectoris Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 37. Europe Angina Pectoris Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Asia-Pacific Angina Pectoris Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 39. Asia-Pacific Angina Pectoris Drugs Market Size by Region (2023-2028) & (US$ Million)
    Table 40. Latin America Angina Pectoris Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Latin America Angina Pectoris Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Middle East & Africa Angina Pectoris Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Middle East & Africa Angina Pectoris Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Pfizer Company Detail
    Table 45. Pfizer Business Overview
    Table 46. Pfizer Angina Pectoris Drugs Product
    Table 47. Pfizer Revenue in Angina Pectoris Drugs Business (2017-2022) & (US$ Million)
    Table 48. Pfizer Recent Development
    Table 49. Bayer Company Detail
    Table 50. Bayer Business Overview
    Table 51. Bayer Angina Pectoris Drugs Product
    Table 52. Bayer Revenue in Angina Pectoris Drugs Business (2017-2022) & (US$ Million)
    Table 53. Bayer Recent Development
    Table 54. AstraZeneca Company Detail
    Table 55. AstraZeneca Business Overview
    Table 56. AstraZeneca Angina Pectoris Drugs Product
    Table 57. AstraZeneca Revenue in Angina Pectoris Drugs Business (2017-2022) & (US$ Million)
    Table 58. AstraZeneca Recent Development
    Table 59. Gilead Company Detail
    Table 60. Gilead Business Overview
    Table 61. Gilead Angina Pectoris Drugs Product
    Table 62. Gilead Revenue in Angina Pectoris Drugs Business (2017-2022) & (US$ Million)
    Table 63. Gilead Recent Development
    Table 64. Novartis Company Detail
    Table 65. Novartis Business Overview
    Table 66. Novartis Angina Pectoris Drugs Product
    Table 67. Novartis Revenue in Angina Pectoris Drugs Business (2017-2022) & (US$ Million)
    Table 68. Novartis Recent Development
    Table 69. GlaxoSmithKline Company Detail
    Table 70. GlaxoSmithKline Business Overview
    Table 71. GlaxoSmithKline Angina Pectoris Drugs Product
    Table 72. GlaxoSmithKline Revenue in Angina Pectoris Drugs Business (2017-2022) & (US$ Million)
    Table 73. GlaxoSmithKline Recent Development
    Table 74. Merck Company Detail
    Table 75. Merck Business Overview
    Table 76. Merck Angina Pectoris Drugs Product
    Table 77. Merck Revenue in Angina Pectoris Drugs Business (2017-2022) & (US$ Million)
    Table 78. Merck Recent Development
    Table 79. Mylan Company Detail
    Table 80. Mylan Business Overview
    Table 81. Mylan Angina Pectoris Drugs Product
    Table 82. Mylan Revenue in Angina Pectoris Drugs Business (2017-2022) & (US$ Million)
    Table 83. Mylan Recent Development
    Table 84. Teva Pharmaceutical Company Detail
    Table 85. Teva Pharmaceutical Business Overview
    Table 86. Teva Pharmaceutical Angina Pectoris Drugs Product
    Table 87. Teva Pharmaceutical Revenue in Angina Pectoris Drugs Business (2017-2022) & (US$ Million)
    Table 88. Teva Pharmaceutical Recent Development
    Table 89. Research Programs/Design for This Report
    Table 90. Key Data Information from Secondary Sources
    Table 91. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Angina Pectoris Drugs Market Share by Type: 2021 VS 2028
    Figure 2. Beta Blockers Features
    Figure 3. Calcium Antagonists Features
    Figure 4. Anticoagulants Features
    Figure 5. Anti-Platelets Features
    Figure 6. Others Features
    Figure 7. Global Angina Pectoris Drugs Market Share by Application in 2021 & 2028
    Figure 8. Hospitals Case Studies
    Figure 9. Clinics Case Studies
    Figure 10. ASCs Case Studies
    Figure 11. Angina Pectoris Drugs Report Years Considered
    Figure 12. Global Angina Pectoris Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Angina Pectoris Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Angina Pectoris Drugs Market Share by Region: 2021 VS 2028
    Figure 15. Global Angina Pectoris Drugs Market Share by Players in 2021
    Figure 16. Global Top Angina Pectoris Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Angina Pectoris Drugs as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Angina Pectoris Drugs Revenue in 2021
    Figure 18. North America Angina Pectoris Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. North America Angina Pectoris Drugs Market Share by Country (2017-2028)
    Figure 20. United States Angina Pectoris Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Angina Pectoris Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Angina Pectoris Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Angina Pectoris Drugs Market Share by Country (2017-2028)
    Figure 24. Germany Angina Pectoris Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. France Angina Pectoris Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. U.K. Angina Pectoris Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Italy Angina Pectoris Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Russia Angina Pectoris Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Nordic Countries Angina Pectoris Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Angina Pectoris Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Angina Pectoris Drugs Market Share by Region (2017-2028)
    Figure 32. China Angina Pectoris Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Japan Angina Pectoris Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. South Korea Angina Pectoris Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Southeast Asia Angina Pectoris Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. India Angina Pectoris Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Australia Angina Pectoris Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Angina Pectoris Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Angina Pectoris Drugs Market Share by Country (2017-2028)
    Figure 40. Mexico Angina Pectoris Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Brazil Angina Pectoris Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Angina Pectoris Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Angina Pectoris Drugs Market Share by Country (2017-2028)
    Figure 44. Turkey Angina Pectoris Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Saudi Arabia Angina Pectoris Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Pfizer Revenue Growth Rate in Angina Pectoris Drugs Business (2017-2022)
    Figure 47. Bayer Revenue Growth Rate in Angina Pectoris Drugs Business (2017-2022)
    Figure 48. AstraZeneca Revenue Growth Rate in Angina Pectoris Drugs Business (2017-2022)
    Figure 49. Gilead Revenue Growth Rate in Angina Pectoris Drugs Business (2017-2022)
    Figure 50. Novartis Revenue Growth Rate in Angina Pectoris Drugs Business (2017-2022)
    Figure 51. GlaxoSmithKline Revenue Growth Rate in Angina Pectoris Drugs Business (2017-2022)
    Figure 52. Merck Revenue Growth Rate in Angina Pectoris Drugs Business (2017-2022)
    Figure 53. Mylan Revenue Growth Rate in Angina Pectoris Drugs Business (2017-2022)
    Figure 54. Teva Pharmaceutical Revenue Growth Rate in Angina Pectoris Drugs Business (2017-2022)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
    Figure 57. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer
Bayer
AstraZeneca
Gilead
Novartis
GlaxoSmithKline
Merck
Mylan
Teva Pharmaceutical
Frequently Asked Questions
Angina Pectoris Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Angina Pectoris Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Angina Pectoris Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Angioplasty Balloons

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More

Aniline

This report aims to provide a comprehensive presentation of the global market for Aniline, with b ... Read More